GlassScriptPhysician profile
Katherine Callaghan
NPI 1710481874
$746.99
in general payments reported to CMS, 2019-2025
12 companies · $258 in 2025
The $258 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.74 · 2022: $83.61 · 2023: $108 · 2024: $275 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.94 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $175.31 | 2024-2025 | Vaxelis, Vaxneuvance, Rotateq |
| Glaxosmithkline, LLC. | $84.61 | 2023-2025 | Bexsero, Pediarix, Rotarix |
| Ironshore Pharmaceuticals INC. | $82.86 | 2023-2024 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $80.40 | 2024-2025 | |
| Pfizer INC. | $69.10 | 2023-2024 | |
| Supernus Pharmaceuticals, INC. | $63.77 | 2022-2023 | Qelbree |
| Corium, LLC | $56.21 | 2025 | Azstarys |
| Tris Pharma INC | $51.15 | 2022-2024 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $26.53 | 2025 | Jornay Pm |
| Horizon Therapeutics Plc | $22.74 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $21.38 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $12.93 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Callaghan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.